These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 19962574)

  • 1. Correction of coagulation in dilutional coagulopathy: use of kinetic and capacitive coagulation assays to improve hemostasis.
    Schols SE; Heemskerk JW; van Pampus EC
    Transfus Med Rev; 2010 Jan; 24(1):44-52. PubMed ID: 19962574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Dilutional coagulopathy: development, diagnostic options and management].
    Fries D
    Hamostaseologie; 2006 Aug; 26(3 Suppl 1):S15-9. PubMed ID: 16953287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Dilutional coagulopathy, an underestimated problem?].
    Fries D; Streif W; Haas T; Kühbacher G
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2004 Dec; 39(12):745-50. PubMed ID: 15605299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired thrombin generation and fibrin clot formation in patients with dilutional coagulopathy during major surgery.
    Schols SE; Lancé MD; Feijge MA; Damoiseaux J; Marcus MA; Hamulyák K; Ten Cate H; Heemskerk JW; van Pampus EC
    Thromb Haemost; 2010 Feb; 103(2):318-28. PubMed ID: 20024495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of massive operative blood loss.
    Kozek-Langenecker S
    Minerva Anestesiol; 2007; 73(7-8):401-15. PubMed ID: 17380100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibrinogen in craniosynostosis surgery.
    Haas T; Fries D; Velik-Salchner C; Oswald E; Innerhofer P
    Anesth Analg; 2008 Mar; 106(3):725-31, table of contents. PubMed ID: 18292409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Haemostaseological aspects of perioperative blood management].
    Scherer RU
    Zentralbl Chir; 2003 Jun; 128(6):473-80. PubMed ID: 12865952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prothrombin complex concentrate (Beriplex P/N) for control of bleeding after kidney trauma in a rabbit dilutional coagulopathy model.
    Pragst I; Kaspereit F; Dörr B; Dickneite G
    Thromb Res; 2010 Mar; 125(3):272-7. PubMed ID: 19913880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of cardiac surgery on hemostasis.
    Hartmann M; Sucker C; Boehm O; Koch A; Loer S; Zacharowski K
    Transfus Med Rev; 2006 Jul; 20(3):230-41. PubMed ID: 16787830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver disease, coagulation testing, and hemostasis.
    Ng VL
    Clin Lab Med; 2009 Jun; 29(2):265-82. PubMed ID: 19665678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemostatic changes after crystalloid or colloid fluid administration during major orthopedic surgery: the role of fibrinogen administration.
    Mittermayr M; Streif W; Haas T; Fries D; Velik-Salchner C; Klingler A; Oswald E; Bach C; Schnapka-Koepf M; Innerhofer P
    Anesth Analg; 2007 Oct; 105(4):905-17, table of contents. PubMed ID: 17898365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protocol and preliminary results of a clinical study for comparison of solvent/detergent-inactivated plasma VIP versus FFP with special consideration of the balance of hemostasis.
    Beck KH; Mortelmans Y; Kretschmer V
    Beitr Infusionsther Transfusionsmed; 1994; 32():440-4. PubMed ID: 9422123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Role of the clinical laboratory for patients with massive transfusion undergoing elective surgery].
    Kino S; Takenaka S; Niizeki N; Hanada D; Tomoda Y; Akasaka K; Ito Y
    Rinsho Byori; 2011 Jul; 59(7):670-5. PubMed ID: 21874793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Global haemostasis and point of care testing.
    Dargaud Y; Sorensen B; Shima M; Hayward C; Srivastava A; Negrier C
    Haemophilia; 2012 Jul; 18 Suppl 4():81-8. PubMed ID: 22726088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of plasma dilution on tissue-factor-induced thrombin generation and thromboelastography: partly compensating role of platelets.
    Schols SE; Feijge MA; Lancé MD; Hamulyák K; ten Cate H; Heemskerk JW; van Pampus EC
    Transfusion; 2008 Nov; 48(11):2384-94. PubMed ID: 18673348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The blood bank: from provider to partner in treatment of massively bleeding patients.
    Johansson PI
    Transfusion; 2007 Aug; 47(2 Suppl):176S-181S; discussion 182S-183S. PubMed ID: 17651347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Technology: Is There Sufficient Evidence to Change Practice in Point-of-Care Management of Coagulopathy?
    Fabbro M; Winkler AM; Levy JH
    J Cardiothorac Vasc Anesth; 2017 Oct; 31(5):1849-1856. PubMed ID: 28844370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Massive transfusion and coagulopathy: pathophysiology and implications for clinical management.
    Hardy JF; De Moerloose P; Samama M;
    Can J Anaesth; 2004 Apr; 51(4):293-310. PubMed ID: 15064258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of acquired coagulopathy in acute paediatrics.
    Morley SL
    Arch Dis Child Educ Pract Ed; 2011 Apr; 96(2):49-60. PubMed ID: 20876597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Massive transfusion: an overview of the main characteristics and potential risks associated with substances used for correction of a coagulopathy.
    Seghatchian J; Samama MM
    Transfus Apher Sci; 2012 Oct; 47(2):235-43. PubMed ID: 22770808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.